Mark Cunningham

Head of Operations, NATA, MRC, UKRI

As Head of Operations at the Nucleic Acid Therapy Accelerator (NATA), part of the UK MRC and UKRI. At NATA we are looking to develop internal capabilities and partner with external scientists in the fields of oligonucleotide chemistry and biology. Previously, at Janssen R&D, I played a variety of roles including ‘Chief of Staff’ for the Immunology Therapeutic Area, ‘Scientific Strategist’ evolving R&D facilities in Philadelphia, PA and San Francisco, CA and ‘Governance Facilitator’ for projects in Early and Late Development phases focused on autoimmune diseases. I want to do a job that I love by taking advantage of my scientific education, R&D experience (in both small and large molecule programs) and by joining a team that enables the development of new healthcare solutions for patients with unmet medical need.

Technology & Innovation Centre

22 September 2022, GLASGOW